Angiogenesis factors involved in the pathogenesis of colorectal cancer

Colorectal cancer stands at the top of oncologic pathology in the world, and in the same measure in Romania because is the third most frequent cancer diagnosed in men and women. Colorectal cancer develops as a result of mutations in genes that control proliferation and cell death. It was established...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current health sciences journal 2014-01, Vol.40 (1), p.5-11
Hauptverfasser: Mihalache, A, Rogoveanu, I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue 1
container_start_page 5
container_title Current health sciences journal
container_volume 40
creator Mihalache, A
Rogoveanu, I
description Colorectal cancer stands at the top of oncologic pathology in the world, and in the same measure in Romania because is the third most frequent cancer diagnosed in men and women. Colorectal cancer develops as a result of mutations in genes that control proliferation and cell death. It was established that in the development of a tumor there is originally a prevascular phase followed by a phase of tumor angiogenesis. In the future it is necessary to develop new clinical protocols that angiogenesis inhibitors are associated with chemo or radiotherapy, conventional or other methods such as immunotherapy and gene therapy.
doi_str_mv 10.12865/CHSJ.40.01.01
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4006338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1540128820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1568-ee6171b9eedb06d22d295f493a1ead848d9aeabec2ea77ef0c8b094b38713b3d3</originalsourceid><addsrcrecordid>eNpVkEtLw0AUhQdRbKndupQs3aTOK_PYCKVYqxRcqOswj5t2JM3UTFrw3zdoLXq5cA_cw3fgIHRN8IRQJYq72eL1ecLxBJN-z9CQYqFzjhk9_9Yyx6IQAzRO6QP3owoilbxEA8qlJkSrIZpPm1WIK2gghZRVxnWxTVlo9rHeg-9F1q0h25pufTLFKnOxji24ztSZM42D9gpdVKZOMD7eEXqfP7zNFvny5fFpNl3mjhRC5QCCSGI1gLdYeEo91UXFNTMEjFdceW3AWHAUjJRQYacs1twyJQmzzLMRuv_hbnd2A95B07WmLrdt2Jj2q4wmlP8_TViXq7gvOcaCMdUDbo-ANn7uIHXlJiQHdW0aiLtUkoLjvltFcW-9-Zt1Cvktjx0AZ6hz-Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1540128820</pqid></control><display><type>article</type><title>Angiogenesis factors involved in the pathogenesis of colorectal cancer</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mihalache, A ; Rogoveanu, I</creator><creatorcontrib>Mihalache, A ; Rogoveanu, I</creatorcontrib><description>Colorectal cancer stands at the top of oncologic pathology in the world, and in the same measure in Romania because is the third most frequent cancer diagnosed in men and women. Colorectal cancer develops as a result of mutations in genes that control proliferation and cell death. It was established that in the development of a tumor there is originally a prevascular phase followed by a phase of tumor angiogenesis. In the future it is necessary to develop new clinical protocols that angiogenesis inhibitors are associated with chemo or radiotherapy, conventional or other methods such as immunotherapy and gene therapy.</description><identifier>ISSN: 2067-0656</identifier><identifier>EISSN: 2069-4032</identifier><identifier>DOI: 10.12865/CHSJ.40.01.01</identifier><identifier>PMID: 24791198</identifier><language>eng</language><publisher>Romania: Medical University Publishing House Craiova</publisher><subject>Review</subject><ispartof>Current health sciences journal, 2014-01, Vol.40 (1), p.5-11</ispartof><rights>Copyright © 2014, Medical University Publishing House Craiova 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1568-ee6171b9eedb06d22d295f493a1ead848d9aeabec2ea77ef0c8b094b38713b3d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006338/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006338/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24791198$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mihalache, A</creatorcontrib><creatorcontrib>Rogoveanu, I</creatorcontrib><title>Angiogenesis factors involved in the pathogenesis of colorectal cancer</title><title>Current health sciences journal</title><addtitle>Curr Health Sci J</addtitle><description>Colorectal cancer stands at the top of oncologic pathology in the world, and in the same measure in Romania because is the third most frequent cancer diagnosed in men and women. Colorectal cancer develops as a result of mutations in genes that control proliferation and cell death. It was established that in the development of a tumor there is originally a prevascular phase followed by a phase of tumor angiogenesis. In the future it is necessary to develop new clinical protocols that angiogenesis inhibitors are associated with chemo or radiotherapy, conventional or other methods such as immunotherapy and gene therapy.</description><subject>Review</subject><issn>2067-0656</issn><issn>2069-4032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLw0AUhQdRbKndupQs3aTOK_PYCKVYqxRcqOswj5t2JM3UTFrw3zdoLXq5cA_cw3fgIHRN8IRQJYq72eL1ecLxBJN-z9CQYqFzjhk9_9Yyx6IQAzRO6QP3owoilbxEA8qlJkSrIZpPm1WIK2gghZRVxnWxTVlo9rHeg-9F1q0h25pufTLFKnOxji24ztSZM42D9gpdVKZOMD7eEXqfP7zNFvny5fFpNl3mjhRC5QCCSGI1gLdYeEo91UXFNTMEjFdceW3AWHAUjJRQYacs1twyJQmzzLMRuv_hbnd2A95B07WmLrdt2Jj2q4wmlP8_TViXq7gvOcaCMdUDbo-ANn7uIHXlJiQHdW0aiLtUkoLjvltFcW-9-Zt1Cvktjx0AZ6hz-Q</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Mihalache, A</creator><creator>Rogoveanu, I</creator><general>Medical University Publishing House Craiova</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201401</creationdate><title>Angiogenesis factors involved in the pathogenesis of colorectal cancer</title><author>Mihalache, A ; Rogoveanu, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1568-ee6171b9eedb06d22d295f493a1ead848d9aeabec2ea77ef0c8b094b38713b3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mihalache, A</creatorcontrib><creatorcontrib>Rogoveanu, I</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current health sciences journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mihalache, A</au><au>Rogoveanu, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiogenesis factors involved in the pathogenesis of colorectal cancer</atitle><jtitle>Current health sciences journal</jtitle><addtitle>Curr Health Sci J</addtitle><date>2014-01</date><risdate>2014</risdate><volume>40</volume><issue>1</issue><spage>5</spage><epage>11</epage><pages>5-11</pages><issn>2067-0656</issn><eissn>2069-4032</eissn><abstract>Colorectal cancer stands at the top of oncologic pathology in the world, and in the same measure in Romania because is the third most frequent cancer diagnosed in men and women. Colorectal cancer develops as a result of mutations in genes that control proliferation and cell death. It was established that in the development of a tumor there is originally a prevascular phase followed by a phase of tumor angiogenesis. In the future it is necessary to develop new clinical protocols that angiogenesis inhibitors are associated with chemo or radiotherapy, conventional or other methods such as immunotherapy and gene therapy.</abstract><cop>Romania</cop><pub>Medical University Publishing House Craiova</pub><pmid>24791198</pmid><doi>10.12865/CHSJ.40.01.01</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2067-0656
ispartof Current health sciences journal, 2014-01, Vol.40 (1), p.5-11
issn 2067-0656
2069-4032
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4006338
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Angiogenesis factors involved in the pathogenesis of colorectal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T22%3A43%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiogenesis%20factors%20involved%20in%20the%20pathogenesis%20of%20colorectal%20cancer&rft.jtitle=Current%20health%20sciences%20journal&rft.au=Mihalache,%20A&rft.date=2014-01&rft.volume=40&rft.issue=1&rft.spage=5&rft.epage=11&rft.pages=5-11&rft.issn=2067-0656&rft.eissn=2069-4032&rft_id=info:doi/10.12865/CHSJ.40.01.01&rft_dat=%3Cproquest_pubme%3E1540128820%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1540128820&rft_id=info:pmid/24791198&rfr_iscdi=true